CXCR4 and pancreatic neoplasm: Regarding the gene expression of MSH2 and CXCR4 we were able to detect a downregulation (−2.80-fold) of MSH2 in hepatic metastases and (−2.63-fold) of MSH2 in the primary pancreatic tumor compared to both corresponding healthy tissue.